Isoenzyme specific PFK-2/FBPas-2 inhibition as an anti-cancer strategy
<p>High aerobic glycolytic capacity is correlated with poor prognosis and increased tumour aggressiveness. 6Phosphofructo-1-kinase catalyses the first irreversible step of glycolysis, and is activated by fructose-2,6-bisphosphate, a product of the kinase activity of four bifunctional isoenzyme...
Main Author: | Williams, J |
---|---|
Other Authors: | Harris, A |
Format: | Thesis |
Language: | English |
Published: |
2013
|
Subjects: |
Similar Items
-
Isoenzyme-specific PFK-2/FBPase-2 Inhibition as an Anti-cancer Strategy
by: Williams, J, et al.
Published: (2012) -
Design, synthesis and biological evaluation of glycosidase inhibitors in an anti-cancer setting
by: Glawar, AFG
Published: (2013) -
Development of models and methods to assess the efficacy of anti-cancer drugs targeted to the mitochondria
by: Potter, M
Published: (2014) -
Cytoplasmic p21WAF1/CIP1 expression is correlated with HER-2/neu in breast cancer and is an independent predictor of prognosis
by: Winters, Z, et al.
Published: (2003) -
The synthesis and biological evaluation of novel N-acetylhexosaminidase inhibitors
by: Crabtree, E, et al.
Published: (2011)